Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China
· Delayed Price · Currency is CNY 24.35
+0.95 (4.06%)
Apr 29, 2026, 3:00 PM CST
SHA:688393 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -41.57 | -50.8 | 21.29 | 40.06 | 42.69 | 79.78 | Upgrade
|
| Depreciation & Amortization | 42.81 | 42.81 | 39.7 | 40.99 | 35.69 | 18.58 | Upgrade
|
| Other Amortization | 8.99 | 8.99 | 6.77 | 6.02 | 4 | 3.34 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.25 | 0.25 | -0.33 | -0.36 | 0.02 | -0.31 | Upgrade
|
| Asset Writedown & Restructuring Costs | 15.49 | 15.49 | 3.85 | 4.06 | 0.12 | 0.93 | Upgrade
|
| Loss (Gain) From Sale of Investments | -17.5 | -17.5 | -5.35 | -5.14 | 3.14 | -12.86 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 5.67 | 4.5 | 5.35 | 1.69 | Upgrade
|
| Other Operating Activities | -33.08 | -1.15 | -9.9 | -22.24 | -11.39 | -2.68 | Upgrade
|
| Change in Accounts Receivable | 69.18 | 69.18 | -7.45 | -9.29 | -36.17 | -35 | Upgrade
|
| Change in Inventory | -16.67 | -16.67 | -30.23 | -30.49 | -23.07 | -16.65 | Upgrade
|
| Change in Accounts Payable | 4.86 | 4.86 | -5.41 | -6.17 | -7.04 | 17.02 | Upgrade
|
| Change in Other Net Operating Assets | -7.09 | -7.09 | -6.43 | 5.83 | - | - | Upgrade
|
| Operating Cash Flow | 17.31 | 40.02 | 3.54 | 17.12 | 9.72 | 59.61 | Upgrade
|
| Operating Cash Flow Growth | -45.75% | 1029.39% | -79.31% | 76.21% | -83.70% | -34.80% | Upgrade
|
| Capital Expenditures | -23.53 | -23.15 | -23.65 | -37.74 | -72.17 | -143.34 | Upgrade
|
| Sale of Property, Plant & Equipment | -0 | - | 0.03 | 2.93 | 2.2 | 2.93 | Upgrade
|
| Cash Acquisitions | -7.13 | -7.13 | - | -1.25 | - | -31.85 | Upgrade
|
| Investment in Securities | 4.62 | -62.26 | 77.22 | 0.9 | -52.33 | -281.67 | Upgrade
|
| Other Investing Activities | 19.55 | 17.96 | 3.51 | 2.47 | 7.37 | 7.32 | Upgrade
|
| Investing Cash Flow | -6.49 | -74.58 | 57.12 | -32.7 | -114.92 | -446.61 | Upgrade
|
| Short-Term Debt Issued | - | - | 7.3 | 21.2 | 14.3 | 7 | Upgrade
|
| Long-Term Debt Issued | - | 0.15 | - | - | - | - | Upgrade
|
| Total Debt Issued | 0.15 | 0.15 | 7.3 | 21.2 | 14.3 | 7 | Upgrade
|
| Short-Term Debt Repaid | - | - | -21.2 | -14.3 | -7 | - | Upgrade
|
| Long-Term Debt Repaid | - | -7.3 | -2.14 | -2.51 | -2.67 | -2.53 | Upgrade
|
| Total Debt Repaid | -2.15 | -7.3 | -23.34 | -16.81 | -9.67 | -2.53 | Upgrade
|
| Net Debt Issued (Repaid) | -2 | -7.15 | -16.04 | 4.39 | 4.63 | 4.47 | Upgrade
|
| Issuance of Common Stock | - | - | - | 2.18 | - | - | Upgrade
|
| Common Dividends Paid | -9.53 | -9.53 | -14.51 | -13.47 | -26.61 | -26.33 | Upgrade
|
| Other Financing Activities | -11.4 | -10.89 | -4.17 | - | 0.58 | -7.67 | Upgrade
|
| Financing Cash Flow | -22.93 | -27.57 | -34.72 | -6.89 | -21.4 | -29.53 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.04 | -0.04 | -0.12 | 0.08 | 0.14 | -0.06 | Upgrade
|
| Net Cash Flow | -12.15 | -62.17 | 25.82 | -22.39 | -126.46 | -416.58 | Upgrade
|
| Free Cash Flow | -6.22 | 16.87 | -20.1 | -20.62 | -62.45 | -83.73 | Upgrade
|
| Free Cash Flow Margin | -1.77% | 4.90% | -4.27% | -4.15% | -12.31% | -19.07% | Upgrade
|
| Free Cash Flow Per Share | -0.07 | 0.18 | -0.22 | -0.22 | -0.66 | -0.89 | Upgrade
|
| Cash Income Tax Paid | 30.84 | 28.16 | 31.1 | 27.31 | 23.13 | 17.02 | Upgrade
|
| Levered Free Cash Flow | 273.2 | 195.23 | -91.53 | -108.95 | -69.45 | -122.56 | Upgrade
|
| Unlevered Free Cash Flow | 273.2 | 195.23 | -91.12 | -108.45 | -68.6 | -122.32 | Upgrade
|
| Change in Working Capital | 41.92 | 41.92 | -58.17 | -50.77 | -69.9 | -28.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.